An Anti-Infectives pharmaceutical company that has developed and patented a portfolio of drugs, which have a completely different mode of action from conventional antibiotics. These compounds have been shown to work in such a way that bacteria are unable to develop resistance to repeated dosing. They can therefore be used to treat and prevent ""Superbugs"" such as methicillin-resistant Staphylococcus aureus (MRSA), one of the major unmet needs of Western medicine.